Marubeni Pharma launches Xenleta for CAP treatment in China, marking a breakthrough in antibiotics. The drug is included in the national medical insurance list, improving patient access.
JPMorgan: Crypto Market Structure Act likely to pass mid-year
JPMorgan predicts the Crypto Market Structure Act will likely pass by mid-2026, potentially transforming the crypto market and attracting institutional investors.